|
Volumn 141, Issue 2, 2012, Pages 547-548
|
Modernization of traditional Chinese medicine
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIMALARIAL AGENT;
ARTEMISININ;
BICYCLOL;
DIGESTIVE TRACT AGENT;
GLYCOPROTEIN P INHIBITOR;
HUPERZINE A;
UNCLASSIFIED DRUG;
ALLOPATHY;
ANTIINFLAMMATORY ACTIVITY;
ARISTOLOCHIA;
CHINA;
CHINESE;
CHINESE MEDICINE;
CLEMATIS;
CLINICAL PRACTICE;
EDITORIAL;
EXPERIENCE;
EXPERIMENTAL MODEL;
HEALTH;
HERB;
HERB DRUG INTERACTION;
HUMAN;
KIDNEY INJURY;
MEDICINAL PLANT;
MOLECULAR BIOLOGY;
NONHUMAN;
PUBLICATION;
RESEARCH;
DRUGS, CHINESE HERBAL;
GUIDELINE ADHERENCE;
HUMANS;
MEDICINE, CHINESE TRADITIONAL;
PATIENT SAFETY;
PRACTICE GUIDELINES AS TOPIC;
QUALITY CONTROL;
RISK ASSESSMENT;
SOCIAL CHANGE;
|
EID: 84861181598
PISSN: 03788741
EISSN: 18727573
Source Type: Journal
DOI: 10.1016/j.jep.2012.05.001 Document Type: Editorial |
Times cited : (27)
|
References (0)
|